Matches 1 - 50 out of 252 1 2 3 4 5 6 >


Match Document Document Title
US20110097281 FOAM SKIN CARE CREAM  
The present invention relates to a formulation comprising an aqueous emulsion and a blowing agent for a foaming skin cream, a distinctive feature thereof being that the emulsion comprises microsilver.
US20110038807 COMPOSITIONS AND METHODS FOR TREATING BIPOLAR DISORDER  
The present invention is directed to a method for treating bipolar disorder, childhood-onset bipolar disorder, and associated symptoms. The method includes administering to a subject in need of...
US20120111324 Dry Powder Drug Delivery Formulations, Methods of Use, and Devices Therefore  
The present disclosure relates to systems, methods, and formulations for the pulmonary administration of one or more therapeutic agents, in dry powder form, in a single, large dose quantity. These...
US20110206771 Encapsulated functional fine particle composition capable of spraying and preparation method thereof  
Provided is an encapsulated functional fine particle composition capable of spraying that is useful for hemostasis and wound protection and allows a patient to treat the wound by oneself....
US20110262502 PULMONARY DELIVERY OF 17-HYDROXYPROGESTERONE CAPROATE (17-HPC)  
The invention relates to 17-HPC pulmonary formulations for administration by inhalation comprising 17-HPC and a pharmaceutically acceptable excipient. Particle size reduction of 17-HPC is required...
US20120128738 Theobromine for the Treatment of Cough  
The present invention is theobromine as an active agent to be delivered via the inhaled route, for the treatment of cough.
US20060239934 SUPERIOR CONTROL OF BLOOD GLUCOSE IN DIABETES TREATMENT  
Methods related to the treatment of diabetes and improving the control of blood glucose levels are provided. In particular, methods are provided for effectively reducing postprandial glucose...
US20070160543 Haemostatic sprays and compositions  
The present invention is directed to a powder delivery system containing a composition comprising gelatine or collagen powder having a mean particle size of at least 10 μm. The gelatine or...
US20060171899 Water-stabilized aerosol formulation system and method of making  
The invention relates to an aerosol formulation system comprising a primary package system and an aerosol formulation therein wherein the aerosol formulation comprises insulin, a propellant and an...
US20060120972 9-(N-methyl-piperidyliden-4)-thioxanthene for treatment of pulmonary hypertension  
Pimethixene is used as a medicament for the treatment of pulmonary hypertension.
US20110097282 New Use For Budesonide and Formoterol  
The invention provides the use of formoterol and budesonide in the treatment of chronic obstructive pulmonary disease.
US20150225334 ACETAMIDE STEREOISOMER  
The compound of formula (I) is a water-stable, long acting β2-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible...
US20050220722 Method of decreasing fasting sugars and weight gains in diabetic patients  
Inhaled insulin, relative to subcutaneously and/or transdermally administered insulin, can be used to prevent the rate of weight gain and to lower the levels of fasting glucose in diabetic patients.
US20070218013 Aerosolized Fosfomycin/Aminoglycoside Combination for the Treatment of Bacterial Respiratory Infections  
A fosfomycin plus tobramycin combination formulation for delivery by aerosolization is described. The concentrated fosfomycin tobramycin combination formulation containing an efficacious amount of...
US20060153778 Methods and compositions for minimizing accrual of inhalable insulin in the lungs  
Inhalable insulin compositions are provided that rapidly clear from the lungs of patients. Additionally, methods of minimizing insulin accrual after administration of an inhaled insulin...
US20070178051 STERILIZED NANOPARTICULATE GLUCOCORTICOSTEROID FORMULATIONS  
The invention is directed sterile to compositions of glucocorticosteroids useful in the prophylaxis and chronic treatment of asthma and other allergic and inflammatory conditions in adults and...
US20060193788 Acute treatment of headache with phenothiazine antipsychotics  
Methods of treating headache with antipsychotics are provided. A kit for treating headache is also provided, comprising an antipsychotic and a device for rapid delivery of the antipsychotic.
US20060216353 Nanoparticulate corticosteroid and antihistamine formulations  
Compositions comprising a nanoparticulate corticosteroid and an antihistamine are described. The compositions are useful in the prophylaxis and chronic treatment of asthma in adults and pediatric...
US20070154407 INHALER AND STORE FOR A DRY MEDICAMENT FORMULATION AND RELATED METHODS AND USE THEREOF  
An inhaler, a store and a method for atomizing a dry medicament formulation are disclosed. The medicament formulation is first dissolved by a liquid solvent and then atomized together with the...
US20070128124 Aerosolized capreomycin for inhibition of pulmonary tuberculosis  
The invention provides systems, methods, and compositions for the aerosolized administration of capreomycin to persons in need thereof. Administration of capreomycin by aerosol can be used to...
US20120128777 COMPOSITIONS CONTAINING LIPID MICRO- OR NANOPARTICLES FOR THE ENHANCEMENT OF THE DERMAL ACTION OF SOLID PARTICLES  
The invention is related to compositions which can be used as dermal formulations for supporting the skin to restore normal conditions in case of e.g. irritated skin, or to support medical therapy...
US20050008580 Hemophilia treatment by inhalation of coagulation factors  
Hemophilia treatment by the inhalation of coagulation factors. Dry powder Factor IX is aerosolized to a mass median aerodynamic diameter of 4 μm or less, with at least 90% monomer content, at...
US20100284940 METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT PROFILE  
Pharmaceutical compositions containing dihydroergotamine (DHE) and methods in which DHE is administered to patients for treatment of migraine without side effects or adverse effects are disclosed....
US20050152845 Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form  
A compound of formula (I) in the form of a substantially amorphous solid, and processes for the production thereof.
US20050249676 Pullulan capsules  
The invention is a hard capsule comprising pullulan in an amount of 85% to 90% by weight, potassium chloride in an amount of 1.0% to 1.5% by weight, carrageenan in an amount of 0.1% to 0.4% by...
US20060110333 Composition for nasal absorption  
This invention attempts to provide a composition for intranasal administration which has markedly lower risk of developing side effects compared to oral formulation, which promptly exhibits...
US20070196285 Novel combination of anticholinergics - B2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases  
The invention relates to novel combinations based on anticholinergics, β2-adrenoceptor agonists, PDE 4 Inhibitors, glucocorticoids, and leukotriene-receptor antagonists, process for their...
US20060104915 Aerosol dentifrice formulation  
An aerosol dentifrice formulation is provided comprising a high water based system, a specific particle size abrasive and a liquified gas propellant, characterised in that the liquified gas...
US20050042177 Novel compositions of sildenafil free base  
The present invention is directed to nanoparticulate compositions comprising sildenafil free base. The sildenafil free base particles of the composition have an effective average particle size of...
US20050158250 Composition of insulin for nasal administration  
Provided is an insulin-containing granulated composition for nasal administration comprising a crystalline cellulose aggregate having a specific particle diameter distribution as a carrier. Such...
US20090258040 STEROID TREATMENT FOR HOT FLASHES  
Embodiments of the invention relate to methods for treating individuals suffering from hot flashes by vomeronasally administering a therapeutically effective dosage of a steroid agent. The hot...
US20060009435 Synthesis and powder preparation of fluticasone propionate  
An improved process for preparing fluticasone propionate, performed in the presence of water, is disclosed. Further disclosed is a process for preparing a fluticasone propionate that is highly...
US20070065374 Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations  
Nanoparticulate compositions comprising a corticosteroid and a leukotriene receptor antagonist are described. The compositions are useful in the prophylaxis and chronic treatment of asthma in...
US20080107609 PULMONARY DISEASE TREATMENT  
The invention relates to treating chronic obstructive pulmonary disease, involving the administration by inhalation of mometasone furoate particles in daily doses where at least about 250 μg of...
US20100095963 PHARMACEUTICAL COMPOSITIONS  
Disclosed are aerosolized formulations for the treatment of asthma that contain mometasone furoate and processes for preparing the same.
US20050163725 Method for administration of growth hormone via pulmonary delivery  
The claimed invention relates to a method of treating a human patient with growth hormone deficiency or a non-growth hormone deficiency disorder treatable with hGH, which comprises administering...
US20070292519 METHOD OF PRODUCING A NICOTINE MEDICAMENT AND A MEDICAMENT MADE BY THE METHOD  
A method of producing a nicotine medicament for use in an inhaler comprises combining a nicotine formulation, a sugar and a liquid carrier including water to produce a flowable mixture and drying...
US20050121026 Method for administration of tiotropium  
A method for administration and preparation of pharmaceutical dry powder doses are disclosed. The metered dry powder doses are formed from a finely divided dry powder of an selected...
US20070059252 Freeze-dried fsh/lh formulations  
The invention relates to the field of pharmaceutical formulations of a mixture of follicle stimulating hormone (FSH) and luteinising hormone (LH), and to methods of producing such formulations.
US20080317862 Organic Compounds Comprising a Glycopyrrolium Salt  
Medicaments comprising (A) an antimuscarinic agent and (B) a corticosteroid for the treatment of inflammatory or obstructive airways diseases.
US20050042171 Pharmaceutical combinations comprising salmeterol and fluticasone proprionate for the treatment of asthma  
Methods for the prophylaxis or treatment of asthma by once daily administration of salmeterol and fluticasone propionate combinations as well as suitable pharmaceutical formulations are disclosed.
US20060127323 Formoterol and ciclesonide combination  
The invention relates to pharmaceutical compositions containing combinations of formoterol and ciclesonide and the use of such pharmaceutical compositions in medicine, in particular, the...
US20060115432 New powdered inhalants based on modified lactose mixtures as excipient  
The invention relates to a new process for preparing modified lactose mixtures, these lactose mixtures per se and compositions of medicaments for powder inhalation consisting of one or more...
US20060147387 Process to minimize loss through adhesion to equipment surfaces  
The invention relates to a new process for preparing combination formulations of inhaled glucocorticoids and beta 2-agonists e.g. budesonide in combination with formoterol. The process aims at...
US20050042172 Administration of medicaments by vaporisation  
A method of making a medicament which is a vapour comprising heating a composition to a temperature not exceeding 500° C. for a time of less than 10 seconds. The composition is non-volatile at 75°...
US20100015217 Enhancing Pulmonary Host Defense via Administration of Granulocyte-Macrophage Colony Stimulating Factor  
The present invention provides methods for enhancing pulmonary host defense in a subject by administering via inhalation an effective amount of granulocyte-macrophage colony stimulating factor or...
US20050152846 Formoterol superfine formulation  
The present invention relates to a pharmaceutical formulation for use in the administration of a long-acting β2-agonist by inhalation. In particular this invention relates to a chemically stable...
US20060246009 Novel Crystalline Forms of Tiotropium Bromide  
The invention relates to new crystalline forms of tiotropium bromide, processes for preparing them and their use for preparing a pharmaceutical composition for the treatment of respiratory...
US20070154494 Anthrax vaccines and delivery methods  
Immunogenic anthrax compositions, such as anthrax vaccines, and methods for delivering immunogenic anthrax compositions and/or vaccines to a mammal. Methods include delivery to mucosal membranes...
US20050271597 Prostate hypertrophy treatment composition and method  
The present invention provides a method and composition for treatment of benign prostate hyperplasia (BPH) in men via a transscrotal delivery system. The composition of the present invention...

Matches 1 - 50 out of 252 1 2 3 4 5 6 >